ATE270112T1 - Streptococcus equi impfstoff - Google Patents

Streptococcus equi impfstoff

Info

Publication number
ATE270112T1
ATE270112T1 AT98202512T AT98202512T ATE270112T1 AT E270112 T1 ATE270112 T1 AT E270112T1 AT 98202512 T AT98202512 T AT 98202512T AT 98202512 T AT98202512 T AT 98202512T AT E270112 T1 ATE270112 T1 AT E270112T1
Authority
AT
Austria
Prior art keywords
streptococcus equi
equi vaccine
vaccine
vaccines
manufacture
Prior art date
Application number
AT98202512T
Other languages
English (en)
Inventor
Antonius Arnoldus Chris Jacobs
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32669079&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE270112(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE270112T1 publication Critical patent/ATE270112T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/829—Bacterial vaccine for equine species, e.g. horses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/885—Streptococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT98202512T 1997-07-29 1998-07-27 Streptococcus equi impfstoff ATE270112T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97202365 1997-07-29

Publications (1)

Publication Number Publication Date
ATE270112T1 true ATE270112T1 (de) 2004-07-15

Family

ID=32669079

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98202512T ATE270112T1 (de) 1997-07-29 1998-07-27 Streptococcus equi impfstoff

Country Status (10)

Country Link
US (1) US6120775A (de)
EP (1) EP0894500B1 (de)
JP (1) JP4563520B2 (de)
AT (1) ATE270112T1 (de)
CA (1) CA2243730C (de)
DE (1) DE69824794T2 (de)
DK (1) DK0894500T3 (de)
ES (1) ES2224331T3 (de)
HU (1) HU223762B1 (de)
PT (1) PT894500E (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6682745B1 (en) 1998-07-28 2004-01-27 Christiaan Antonius Arnoldus Jacobs Use of bacterium for manufacture of a vaccine
EP1023903B1 (de) * 1999-01-26 2004-01-14 Akzo Nobel N.V. Verwendung lebender abgeschwächter Bakterien zur Herstellung eines submukosalen Impstoffes
GB2370770B (en) * 2001-01-03 2005-06-01 Simon Connolly Uses of Streptococcus Vaccines
US20030129161A1 (en) * 2001-09-17 2003-07-10 Hsien-Jue Chu Interleukin-12 as a veterinary vaccine adjuvant
GB0404586D0 (en) * 2004-03-01 2004-04-07 Britannia Pharmaceuticals Ltd Improvements in or relating to organic materials
US20100021498A1 (en) * 2006-03-28 2010-01-28 Jeffrey Weiser Live, attenuated pneumococcal vaccine
EP2019687B1 (de) * 2006-03-29 2014-03-19 Merial Limited Impfstoff gegen streptokokken
WO2009075646A1 (en) * 2007-12-13 2009-06-18 Bengt Guss Improved immunizing composition
EA029938B1 (ru) * 2015-04-09 2018-05-31 Тоо "Акынтай" Вакцина против мыта лошадей

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110433A (en) * 1976-04-23 1978-08-29 Philips Roxane, Inc. Equine rhinopneumonitis virus
WO1982004396A1 (en) * 1981-06-19 1982-12-23 Russell Roy Robert Baird Protection against dental caries
AR241545A1 (es) * 1985-07-12 1992-08-31 Cornell Res Foundation Inc Un metodo para preparar una cepa de s. equi avirulenta a.t.c.c. 53186 para equinos.
US4788059A (en) * 1985-07-15 1988-11-29 Coopers Animal Health, Inc. Equine strangles vaccine and the method of preparing and using the same
IL86583A0 (en) * 1987-06-04 1988-11-15 Molecular Eng Ass Vaccine containing a derivative of a microbe and method for the production thereof
JPH04501351A (ja) * 1987-10-07 1992-03-12 ワシントン ユニバーシティ 細胞の遺伝的集団において所望の組換え遺伝子を維持する方法
ZA97452B (en) * 1996-01-25 1997-08-15 Trinity College Dublin Streptococcus equi vaccine.

Also Published As

Publication number Publication date
CA2243730C (en) 2009-12-22
PT894500E (pt) 2004-10-29
DE69824794T2 (de) 2004-11-25
DK0894500T3 (da) 2004-11-15
EP0894500B1 (de) 2004-06-30
HUP9801705A2 (hu) 1999-05-28
EP0894500A1 (de) 1999-02-03
HUP9801705A3 (en) 2001-11-28
HU223762B1 (hu) 2005-01-28
ES2224331T3 (es) 2005-03-01
CA2243730A1 (en) 1999-01-29
DE69824794D1 (de) 2004-08-05
US6120775A (en) 2000-09-19
JPH11100329A (ja) 1999-04-13
JP4563520B2 (ja) 2010-10-13
HU9801705D0 (en) 1998-09-28

Similar Documents

Publication Publication Date Title
PT865297E (pt) Composicoes de vacinas para administracao intranasal compreendendo quitosano e suas utilizacoes
CY2009014I2 (el) Εμβολιο εναντι αντιγονων απο βακτηριδια
CY1106234T1 (el) Συνθεσεις για τη θepαπεια μολυνσεων staphylococcus aureus
DE69117532D1 (de) Orale präparate
ATE556596T1 (de) Regulierte attenuierung von lebendimpfstoffen zur verbesserung der kreuzimmunitätsschutzfunktion
BRPI9912663B8 (pt) vacina contra cáncer e polipeptìdeo.
HUP0203056A1 (hu) Vakcinakészítmény
CY1107550T1 (el) Συνδυαστικα εμβολια μηνιγγιτιδας b/c
DE602004024542D1 (de) Untereinheit-impfstoff gegen das respiratorische synzytialvirus
BRPI9700768B8 (pt) vacina viva para combater infecção por streptococcus em cavalos.
HUP0302636A2 (hu) Hasított burkolt víruskészítmény
HUP0301634A2 (hu) Hőmérséklet-érzékeny, élő vakcina Mycoplasma hyopneumoniaera
DK0894500T3 (da) Streptococcus equi-vaccine
ATE377428T1 (de) Rotavirus-impfstoff
PT1112747E (pt) Vacina de salmonella que nao induz anticorpos contra flagelina ou flagelos
ES2137310T3 (es) Vacuna contra una infeccion por streptococcus suis.
DK1109574T3 (da) Vaccine mod seksuelt overförte sygdomme
ATE249740T1 (de) Orale antimikrobielle und desodoriende zusammensetzungen
ES2136064T3 (es) Vacunas de toxoide de pasteurella multocida.
DK1073447T3 (da) N1-modificerede glycopeptider
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
FR2661809B3 (fr) Diffuseur personnel de parfum ou de desodorisant.
MX9202293A (es) Composicion de vacuna no-irritante.
SE9000300D0 (sv) Surgoerande komposition
EP0178928A3 (de) Impfstoffe

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0894500

Country of ref document: EP

REN Ceased due to non-payment of the annual fee